Compositions and methods for targeted delivery to cells
US-2024390271-A1 · Nov 28, 2024 · US
Biocatalysts for ezetimibe synthesis
US9040262B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9040262-B2 |
| Application number | US-201113695856-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 4, 2011 |
| Priority date | May 4, 2010 |
| Publication date | May 26, 2015 |
| Grant date | May 26, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present disclosure relates to non-naturally occurring polypeptides useful for preparing Ezetimibe, polynucleotides encoding the polypeptides, and methods of using the polypeptides.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for preparing compound of Formula (Ia) in diastereomeric excess wherein, X is C or S; R 1 is selected from —H, —F, —Cl, —Br, or —I; R 2 is selected from —H, —F, —Cl, —Br, —I, —CN, —OH (optionally protected with a hydroxyl protecting group), —CH 2 NH 2 (optionally protected with a nitrogen protecting group), and an…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
- C07K14/47Primary
Chemistry & Metallurgy · mapped topic
- C12N9/0006Primary
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9040262B2 cover?
- The present disclosure relates to non-naturally occurring polypeptides useful for preparing Ezetimibe, polynucleotides encoding the polypeptides, and methods of using the polypeptides.
- Who is the assignee on this patent?
- Crowe Michael, Alvizo Oscar, Behrouzian Behnaz, and 10 more
- What technology area does this patent fall under?
- Primary CPC classification C07K14/47. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).